Dorc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DORC
DORC has two approved drugs.
Drugs and US Patents for Dorc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dorc | VISIONBLUE | trypan blue | SOLUTION;OPHTHALMIC | 021670-001 | Dec 16, 2004 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Dorc | MEMBRANEBLUE | trypan blue | SOLUTION;OPHTHALMIC | 022278-001 | Feb 20, 2009 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Dorc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dorc | MEMBRANEBLUE | trypan blue | SOLUTION;OPHTHALMIC | 022278-001 | Feb 20, 2009 | 6,372,449 | ⤷ Start Trial |
| Dorc | VISIONBLUE | trypan blue | SOLUTION;OPHTHALMIC | 021670-001 | Dec 16, 2004 | 6,367,480 | ⤷ Start Trial |
| Dorc | MEMBRANEBLUE | trypan blue | SOLUTION;OPHTHALMIC | 022278-001 | Feb 20, 2009 | 6,696,430 | ⤷ Start Trial |
| Dorc | VISIONBLUE | trypan blue | SOLUTION;OPHTHALMIC | 021670-001 | Dec 16, 2004 | 6,720,314 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

